von Graefe A. Beiträge zur pathologie und therapie des glaucoms. Arch Ophthalmol. 1869;15:108–252 (in German).

Google Scholar 

Chandler PA, Simmons RJ, Grant WM. Malignant glaucoma: medical and surgical treatment. Am J Ophthalmol. 1968;66:495–502.

Article  CAS  PubMed  Google Scholar 

Krix-Jachym K, Żarnowski T, Rękas M. Risk factors of malignant glaucoma occurrence after glaucoma surgery. J Ophthalmol. 2017;2017:9616738.

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Tan Q, Jiang H, Xia X, Wang P, Jiang J, et al. Clinical analysis of malignant glaucoma after glaucoma surgery. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015;40:543–8 (in Chinese).

PubMed  Google Scholar 

Dave P, Senthil S, Rao HL, Garudadri CS. Treatment outcomes in malignant glaucoma. Ophthalmology. 2013;120:984–90.

Article  PubMed  Google Scholar 

Debrouwere V, Stalmans P, Van Calster J, Spileers W, Zeyen T, Stalmans I. Outcomes of different management options for malignant glaucoma: a retrospective study. Graefes Arch Clin Exp Ophthalmol. 2012;250:131–41.

Article  PubMed  Google Scholar 

Little BC, Hitchings RA. Pseudophakic malignant glaucoma: Nd:YAG capsulotomy as a primary treatment. Eye (Lond). 1993;7(Pt 1):102–4.

Article  PubMed  Google Scholar 

Chandler PA. Malignant glaucoma. Trans Am Ophthalmol Soc. 1950;48:128–43.

CAS  PubMed  PubMed Central  Google Scholar 

Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M. One-year postoperative outcomes of filtration minimally invasive glaucoma surgery using the Preserflo® Microshunt for primary open angle glaucoma in japanese patients. Nippon Ganka Gakkai Zasshi. 2020;124:705–12 (in Japanese).

Google Scholar 

Batlle JF, Corona A, Albuquerque R. Long-term results of the Preserflo Microshunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021;30:281–6.

Article  PubMed  Google Scholar 

Beckers HJM, Aptel F, Webers CAB, Bluwol E, Martínez-de-la-Casa JM, García-Feijoó J, et al. Safety and effectiveness of the Preserflo® Microshunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma. 2022;5:195–209.

Article  PubMed  Google Scholar 

Gambini G, Carlà MM, Giannuzzi F, Caporossi T, De Vico U, Savastano A, et al. PreserFlo(®) MicroShunt: an overview of this minimally invasive device for open-angle glaucoma. Vision (Basel). 2022;6:12.

Article  PubMed  Google Scholar 

Ahmed IIK, Sadruddin O, Panarelli JF. Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma. Eye Vis (Lond). 2023;10:10.

Article  PubMed  Google Scholar 

Armstrong JJ, De Francesco T, Ma J, Schlenker MB, Ahmed IIK. Ab externo SIBS microshunt with mitomycin C for open-angle glaucoma: three-year results as a primary surgical intervention. Ophthalmol Glaucoma. 2023;6:480–92.

Article  PubMed  Google Scholar 

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, et al. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: two-year results from a randomized, multicenter study. Ophthalmology. 2024;131:266–76.

Article  PubMed  Google Scholar 

Gizzi C, Costa G, Servadei R, Abed E, Ning B, Sharma A, et al. A case of malignant glaucoma following insertion of Preserflo™ MicroShunt. Eur J Ophthalmol. 2022;32:Np115–9.

Article  PubMed  Google Scholar 

Malick H, Wilde C, Stead RE. Combined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunt. Int J Ophthalmol. 2023;16:652–5.

Article  PubMed  PubMed Central  Google Scholar 

Foreman-Larkin J, Netland PA, Salim S. Clinical management of malignant glaucoma. J Ophthalmol. 2015;2015:283707.

Article  PubMed  PubMed Central  Google Scholar 

Heindl LM, Koch KR, Cursiefen C, Konen W. Optical coherence tomography and ultrasound biomicroscopy in the management of pseudophakic malignant glaucoma. Graefes Arch Clin Exp Ophthalmol. 2013;251:2261–3.

Article  PubMed  Google Scholar 

Burgansky-Eliash Z, Ishikawa H, Schuman JS. Hypotonous malignant glaucoma: aqueous misdirection with low intraocular pressure. Ophthalmic Surg Lasers Imaging. 2008;39:155–9.

Article  PubMed  Google Scholar 

Kumar S, Singla E, Ichhpujani P, Rehman O. Hypotonous malignant glaucoma following glaucoma drainage device implantation. Indian J Ophthalmol. 2021;1:512–4.

Article  Google Scholar 

Mieno H, Mori K, Yoshii K, Okada Y, Ikeda Y, Ueno M, et al. Risk factors and protective strategies for hypotony following preserflo microshunt implantation. Sci Rep. 2025;15:8344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin H, Li J, Zheng X, Wan R, Zhou M, Ding Y, et al. Incidence and characteristics of aqueous misdirection after glaucoma surgery in Chinese patients with primary angle-closure glaucoma. Eye Vis. 2023;10:28.

Article  Google Scholar 

Sadeghi R, Momeni A, Fakhraie G, Eslami Y, Zarei R, Vahedian Z, et al. Management of malignant glaucoma. J Curr Ophthalmol. 2022;34:389–97.

Article  PubMed  Google Scholar 

Wilde C, Morales MU, Kumudhan D, Sim J, Amoaku W. Spontaneous onset pseudophakic malignant glaucoma secondary to zonular weakness and cilio-lenticular block. Oman J Ophthalmol. 2018;11:178–80.

Article  PubMed  PubMed Central  Google Scholar 

Grzybowski A, Kanclerz P. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefes Arch Clin Exp Ophthalmol. 2018;256:135–54.

Article  PubMed  Google Scholar 

Madgula IM, Anand N. Long-term follow-up of zonulo-hyaloido-vitrectomy for pseudophakic malignant glaucoma. Indian J Ophthalmol. 2014;62:1115–20.

Article  PubMed  PubMed Central  Google Scholar 

Rękas M, Krix-Jachym K, Żarnowski T. Evaluation of the effectiveness of surgical treatment of malignant glaucoma in pseudophakic eyes through partial PPV with establishment of communication between the anterior chamber and the vitreous cavity. J Ophthalmol. 2015;2015:873124.

Article  PubMed  PubMed Central  Google Scholar